| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$201,782,322 |
|
|
|
Indirect Value
|
$171,213,609 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$372,995,931 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 17 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BDSX |
Biodesix Inc |
|
• • • |
2023-05-24 |
4 |
B |
$1.25 |
$43,980 |
I/I |
35,308 |
20,510,704 |
0.01 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2023-12-19 |
4 |
S |
$0.21 |
$7,430 |
I/I |
(36,000) |
1,566,956 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2023-12-20 |
4 |
S |
$0.20 |
$7,200 |
I/I |
(36,000) |
63,789 |
0 |
% |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • • |
2013-12-20 |
4 |
D |
$27.54 |
$1,038,616 |
D/D |
(37,713) |
3,354,207 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2023-10-06 |
4 |
S |
$0.30 |
$11,448 |
I/I |
(37,931) |
872,956 |
0 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-03-04 |
4 |
B |
$3.66 |
$146,260 |
D/D |
40,000 |
3,571,672 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-03-10 |
4 |
B |
$3.75 |
$149,952 |
D/D |
40,000 |
3,687,561 |
2.45 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2010-12-13 |
4 |
S |
$79.29 |
$3,171,552 |
D/D |
(40,000) |
1,835,193 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2012-03-21 |
4 |
B |
$16.65 |
$665,928 |
D/D |
40,000 |
3,311,465 |
2.39 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-09-29 |
4 |
B |
$15.18 |
$616,308 |
I/I |
40,600 |
10,823,773 |
2.25 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-05-18 |
4 |
S |
$1.03 |
$42,456 |
I/I |
(41,195) |
9,707,848 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2023-10-04 |
4 |
S |
$0.31 |
$12,867 |
I/I |
(41,399) |
921,557 |
0 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2022-01-18 |
4 |
B |
$3.94 |
$165,133 |
I/I |
41,912 |
18,737,047 |
2.25 |
% |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2009-05-28 |
4 |
B |
$12.14 |
$518,140 |
I/I |
42,666 |
225,833 |
2.1 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
10% Owner |
– – • |
2020-02-11 |
4 |
S |
$7.69 |
$328,225 |
I/I |
(42,697) |
428,396 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-03-26 |
4 |
B |
$2.23 |
$95,415 |
I/I |
42,745 |
331,811 |
1.5 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-06-01 |
4 |
B |
$2.03 |
$88,040 |
D/D |
43,316 |
4,204,509 |
2.45 |
- |
|
| SRCL |
Stericycle Inc |
Chairman |
• • – |
2003-07-14 |
4 |
OE |
$7.25 |
$350,021 |
D/D |
44,436 |
1,378,718 |
|
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2012-11-08 |
5 |
GD |
$0.00 |
$0 |
D/D |
45,000 |
1,389,028 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2017-10-18 |
4 |
B |
$20.14 |
$906,300 |
I/I |
45,000 |
13,040,117 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2022-01-10 |
4 |
B |
$4.34 |
$196,281 |
I/I |
45,226 |
18,563,916 |
2.25 |
% |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2009-05-27 |
4 |
B |
$12.35 |
$564,262 |
I/I |
45,700 |
204,501 |
2.1 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2013-08-16 |
4 |
B |
$8.00 |
$369,968 |
I/I |
46,246 |
9,177,219 |
2.25 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2010-06-10 |
4 |
B |
$10.70 |
$495,385 |
I/I |
46,305 |
587,906 |
2.1 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2006-12-12 |
4 |
S |
$13.70 |
$650,038 |
D/D |
(47,287) |
2,892,275 |
0 |
- |
|
634 Records found
|
|
Page 17 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
